NEW YORK--(BUSINESS WIRE)--
NYU Langone Medical Center announced today President Barack Obama named Jan Vilcek, MD, PhD, professor of microbiology at NYU Langone, and co-inventor of the rheumatoid arthritis drug Remicade®, a recipient of the prestigious National Medal of Technology and Innovation. This year 11 individuals will receive this medal, the highest honor bestowed by the United States Government upon scientists, engineers, and inventors. He will receive his award from President Obama at a White House ceremony later this year.
The award recognizes those who have made lasting contributions to America’s competitiveness and quality of life and helped strengthen the Nation’s technological workforce. Nominees are selected by a distinguished independent committee representing the private and public sectors. Dr. Vilcek is being recognized for his pioneering work on interferons and monoclonal antibodies.
“We congratulate Jan on receiving this noble recognition,” said Robert I. Grossman, MD, dean and CEO, NYU Langone Medical Center. “He is a remarkable scientist whose contributions to science and medicine have touched the lives of so many across the globe, and we are extremely privileged that he is part of the NYU Langone family.”
Dr. Vilcek joined NYU Langone at the age of 31 as an assistant professor of microbiology. He devoted his entire career to the study of a group of natural regulators of the immune system called cytokines. Dr. Vilcek devoted much of his career to the study of interferons, making contributions to the understanding of their nature and helping develop their clinical applications. In the 1980's, Dr. Vilcek and his colleague, Junming Le, PhD, adjunct associate professor of microbiology at NYU Langone, generated an artificial antibody to one type of cytokine that, in close collaboration with the biotechnology company Centocor (now part of Johnson & Johnson, and recently renamed Janssen Biotech), they then developed into a drug that has become known as infliximab or Remicade®. Remicade® has since become approved for the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, psoriasis and psoriatic arthritis. It is estimated that to date over two million patients have been treated with Remicade® in the United States and abroad.
Using funds due to him for his role in the development of Remicade®, Dr. Vilcek and his wife Marica F. Vilcek have generously given more than $120 million to NYU Langone Medical Center to fund scholarships, research, and the new medical student residence hall at NYU School of Medicine. Their ongoing support is an outward display of their deep gratitude for the many opportunities the medical center has provided Dr. Vilcek as his intellectual home.
In addition to their support of NYU Langone, Dr. Vilcek and his wife also established The Vilcek Foundation in 2000 to honor and publicize the enormous contributions immigrants have made to biomedical science and the arts in the United States. The Foundation's mission, where Mrs. Vilcek serves as Vice President and Cofounder, derives in large part from Mrs. Vilcek's interest and professional work in the arts and as an Art Historian.
Dr. Vilcek, a native of Bratislava, Slovakia, received his medical degree from the Comenius University Medical School in Bratislava in 1957, and his Ph.D. from the Institute of Virology, Czechoslovak Academy of Sciences, also based in Bratislava, in 1962. The success of Remicade® has spurred the development of other anti-TNF agents that are being used to treat a variety of inflammatory conditions.
The National Medal of Technology and Innovation was created by statute in 1980 and is administered for the White House by the U.S. Department of Commerce’s Patent and Trademark Office. By highlighting the national importance of technological innovation, the medal is also meant to inspire future generations of Americans to prepare for and pursue technical careers to keep America at the forefront of global technology and economic leadership.
“I am proud to honor these inspiring American innovators,” President Obama said in a statement released by the White House. “They represent the ingenuity and imagination that has long made this Nation great—and they remind us of the enormous impact a few good ideas can have when these creative qualities are unleashed in an entrepreneurial environment.”
About NYU Langone Medical Center:
NYU Langone Medical Center, a world-class, patient-centered, integrated, academic medical center, is one on the nation’s premier centers for excellence in clinical care, biomedical research and medical education. Located in the heart of Manhattan, NYU Langone is composed of four hospitals – Tisch Hospital, its flagship acute care facility; the Rusk Institute of Rehabilitation Medicine, the world’s first university-affiliated facility devoted entirely to rehabilitation medicine; the Hospital for Joint Diseases, one of only five hospitals in the nation dedicated to orthopaedics and rheumatology; and Hassenfeld Pediatric Center, a comprehensive pediatric hospital supporting a full array of children’s health services across the Medical Center – plus the NYU School of Medicine, which since 1841 has trained thousands of physicians and scientists who have helped to shape the course of medical history. The medical center’s tri-fold mission to serve, teach and discover is achieved 365 days a year through the seamless integration of a culture devoted to excellence in patient care, education and research. For more information, go to www.NYULMC.org.
- NYU Langone Medical Center
- President Barack Obama
- rheumatoid arthritis
Deborah (DJ) Sabalusky, 212-404-3567
Recommended for You
They contributed this article to LiveScience's Expert Voices: Op-Ed & Insights as part of their new LiveScience series highlighting issues and developments in emerging technologies. What do Amazon's delivery drones, policy meetings on automotive information technology, Google's ongoing acquisition…LiveScience.com
This morning, UBS increased its price target on shares of CB&I (CBI) to $86 as revenue should increase into 2014 with new nuclear projects ramping up. In the report, UBS reiterated its buy rating. Shares of CB&I were lower, despite the report, falling 2% so far today. Bank of America upgraded [...]Forbes
Brian Reynolds, chief market strategist at Rosenblatt Securities, explains why credit investors "don't care about tapering" and says he's "looking forward to tightening."CNBC
Federal authorities and JPMorgan Chase are expected to settle charges over ties to Bernard L. Madoff, who operated a billion-dollar Ponzi scheme using an account at the bank.The New York Times
While the small-cap space probably offers better overall returns, large caps are not to be avoided, and if an investor is going to follow a large-cap stock picker, you could do worse than Warren Buffett....MarketWatch
Samsung Electronics Co Ltd on Thursday lost its bid to ban sales of Apple Inc's older iPhone and iPad in South Korea after a court dismissed a lawsuit claiming the U.S. firm had infringed on three of Samsung's mobile patents. The lawsuit was part of the tech giants' global courtroom battle dating…Reuters
Deb McEneaney of Sag Harbor, N.Y., was jolted in November when her insurance company notified her that it was canceling a group health plan that had been tailor made for her and her husband and their family-run business. Her insurance broker assured her she had nothing to worry about when the…The Fiscal Times
This is your last chance to take advantage of dozens of tax credits and deductions that are going away.CNBC
Canadian stocks fell to an almost two-month low, led by gold producers as better-than-forecast U.S. retail data fueled speculation the Federal Reserve will reduce stimulus.Bloomberg
Gold fell 2% on Thursday. But, it may not be the potential of a Fed tapering to blame.CNBC: Talking Numbers
State insurance exchange leaders know virtually nothing about the 1,730 people who purchased health coverage available via Your Health Idaho through Nov. 30. Director Amy Dowd said Wednesday that Idaho's ...Associated Press
MetLife Inc., the largest U.S. life insurer, said pending oversight from U.S. regulators poses the biggest challenge to meeting Chief Executive Officer Steve Kandarian’s 2016 return-on-equity goal.Bloomberg
The world's online poker giant is being locked out of New Jersey because of its ongoing ties to its indicted founder, Isai Scheinberg.Forbes
CNBC's Phil LeBeau reports Tesla's Elon Musk is speaking at a Dell conference about Model S manufacture rates and the need for better battery production.CNBC Videos
"We're growing since the privatization. We've been growing at double-digit rates," said Michael Dell, the company's founder, chairman and CEO.CNBC
By Mark Miller CHICAGO (Reuters) - The issue of retirement inequality has caught fire in Washington, D.C., and a report issued this week throws a new log on the flames. The National Institute on Retirement Security (NIRS), a non-profit research group, found that workers of color - especially…Reuters
A Hong Kong court imposed the $3 million civil penalty on Du Jun, who is already serving a jail term for insider trading.The New York Times
Air Canada announced it had placed a firm $6.5 billion order for 61 Boeing 737 MAX narrow-body aircraft, with options on 18 more planes and purchase rights for 30 others. Air Canada said the move would create "one of the world's youngest, most fuel-efficient and simplified airline fleets." "Our…AFP
Automaker Volkswagen said Thursday it was replacing the head of its U.S. division, which has struggled to reach sales goals. The company said Jonathan Browning, 54, was leaving his job as president and ...Associated Press